Search


Current filters:



Clear current filters  or Add more filters

View Option



Results 41-50 of 52 (Search time: 0.004 seconds).

  CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival (Journal article)

  Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer (Journal article)

  Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors (Journal article)

  Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study (Journal article)

  Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study (Journal article)

  Docetaxel in combination with dacarbazine in patients with advanced melanoma (Journal article)

  The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy (Journal article)

  Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapy (Journal article)

  Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1 (Journal article)

  Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience (Journal article)